CLM
NKTR icon

ClearBridge LLC (Maryland)’s Nektar Therapeutics NKTR Stock Holding History

ClearBridge LLC (Maryland)’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-4,433
Closed -$729K – 193
2015
Q3 		$729K Hold
4,433
– – 0.01% 158
2015
Q2 		$832K Buy
4,433
+366
+9% +$63K 0.01% 159
2015
Q1 		$671K Buy
4,067
+94
+2% +$19.3K 0.01% 158
2014
Q4 		$924K Hold
3,973
– – 0.02% 155
2014
Q3 		$719K Hold
3,973
– – 0.01% 157
2014
Q2 		$764K Hold
3,973
– – 0.01% 161
2014
Q1 		$722K Buy
+3,973
New +$786K 0.01% 151

Other funds holding NKTR

O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge LLC (Maryland)'s NKTR Position: Q4 2015 in Review

ClearBridge LLC (Maryland) sold out of Nektar Therapeutics (NKTR) in Q4 2015, closing a stake of 4,433 shares — an estimated $729K sold.

ClearBridge LLC (Maryland) first reported a position in NKTR in Q1 2014 and held it in 7 quarters. The position peaked at $924K in Q4 2014. 179 funds tracked by Wall St. Rank hold NKTR as of Q4 2015.

  • ClearBridge LLC (Maryland) reported no remaining Nektar Therapeutics position as of Q4 2015 after selling out during the quarter.
  • ClearBridge LLC (Maryland) sold 4,433 Nektar Therapeutics shares in Q4 2015, an estimated $729K.
  • ClearBridge LLC (Maryland) first reported a position in Nektar Therapeutics in Q1 2014 and held it in 7 quarters.
  • ClearBridge LLC (Maryland)'s Nektar Therapeutics position peaked at $924K in Q4 2014.
  • 179 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2015.

Based on ClearBridge LLC (Maryland)'s 13F filing for Q4 2015, filed 16 Feb 2016.